Cargando…

Rituximab Administration and Reactivation of HBV

Rituximab is a drug used for the treatment of B-cell non-Hodgkin's lymphoma, and its range of use has expanded to the treatment of collagen diseases such as idiopathic thrombocytopenic purpura and rheumatoid arthritis. One serious complication of rituximab use is the reactivation of dormant hep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsutsumi, Yutaka, Ogasawara, Reiki, Kamihara, Yusuke, Ito, Shinichi, Yamamoto, Yoshiya, Tanaka, Junji, Asaka, Masahiro, Imamura, Masahiro
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003947/ https://www.ncbi.nlm.nih.gov/pubmed/21188195 http://dx.doi.org/10.1155/2010/182067

Ejemplares similares

HCV Virus and Lymphoid Neoplasms
por: Tsutsumi, Yutaka, et al.
Publicado: (2011)

Changes in hepatitis C virus antibody titer and viral RNA load in non-Hodgkin's lymphoma patients after rituximab chemotherapy
por: Tsutsumi, Y, et al.
Publicado: (2009)

Patients with marginal zone dural lymphoma successfully treated with rituximab and bendamustine: A report of two cases
por: Tsutsumi, Yutaka, et al.
Publicado: (2021)

Graft-versus-Leukemia Effect of Nonmyeloablative Stem Cell Transplantation
por: Imamura, Masahiro, et al.
Publicado: (2009)

5-Azacytidine partially restores CD20 expression in follicular lymphoma that lost CD20 expression after rituximab treatment: a case report
por: Tsutsumi, Yutaka, et al.
Publicado: (2016)

New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination
por: Hidaka, Daisuke, et al.
Publicado: (2021)

Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation
por: Pawłowska, Małgorzata, et al.
Publicado: (2019)

Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas
por: Lan, Ting-Yuan, et al.
Publicado: (2023)

Acquired hemophilia A in solid cancer: Two case reports and review of the literature
por: Saito, Makoto, et al.
Publicado: (2018)

Recent Advances in HBV Reactivation Research
por: Guo, Lixia, et al.
Publicado: (2018)

Hepatitis C Virus (HCV)-Ribonucleic Acid (RNA) As a Biomarker for Lymphoid Malignancy with HCV Infection
por: Tsutsumi, Yutaka, et al.
Publicado: (2023)

Early complete response of primary bone marrow B‐cell lymphoma treated with rituximab‐based CHOP therapy, assessed by flow cytometry and immunogloblin heavy chain rearrangement
por: Nabe, Yoshimi, et al.
Publicado: (2021)

Strategies for eliminating death from gastric cancer in Japan
por: ASAKA, Masahiro, et al.
Publicado: (2014)

Medical interventions associated with HBV reactivation: Common and less common
por: Reynolds, Justin A., et al.
Publicado: (2015)

Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management
por: Zannella, Alessandra, et al.
Publicado: (2019)

High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Acquiring Chondrocyte Phenotype from Human Mesenchymal Stem Cells under Inflammatory Conditions
por: Kondo, Masahiro, et al.
Publicado: (2014)

HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation
por: Mavilia, Marianna G., et al.
Publicado: (2018)

Risk of tuberculosis reactivation with rituximab therapy
por: Alkadi, Amjad, et al.
Publicado: (2017)

Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19
por: Sagnelli, Caterina, et al.
Publicado: (2022)

Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan
por: Asaka, Masahiro, et al.
Publicado: (2013)

Efficacy and prognosis of antiviral therapy on hepatitis C following treatment of lymphoma in HCV-positive diffuse large-cell lymphoma
por: Tsutsumi, Yutaka, et al.
Publicado: (2017)

Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation
por: Miyazaki, Yusuke, et al.
Publicado: (2020)

COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature
por: Sagnelli, Caterina, et al.
Publicado: (2022)

Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers
por: Furuta, Mayuko, et al.
Publicado: (2018)

Minimization of administration route errors with subcutaneous rituximab
por: Liptrott, Sarah, et al.
Publicado: (2016)

Rituximab in Membranous Nephropathy
por: Gauckler, Philipp, et al.
Publicado: (2021)

Small molecule CP-31398 induces reactive oxygen species-dependent apoptosis in human multiple myeloma
por: Arihara, Yohei, et al.
Publicado: (2017)

Time-Dependent Structural Alteration of Rituximab Analyzed by LC/TOF-MS after a Systemic Administration to Rats
por: Otani, Yuki, et al.
Publicado: (2017)

A new approach for elimination of gastric cancer deaths in Japan
por: Asaka, Masahiro
Publicado: (2013)

Applications of Electron Spin Resonance Spectrometry for Reactive Oxygen Species and Reactive Nitrogen Species Research
por: Kohno, Masahiro
Publicado: (2010)

Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: a case report
por: Kurozumi, Akira, et al.
Publicado: (2016)

Correction: Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers
por: Furuta, Mayuko, et al.
Publicado: (2018)

HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review
por: Gentile, Giuseppe, et al.
Publicado: (2019)

Narrow-Band Ultraviolet B Phototherapy Ameliorates Acute Graft-Versus-Host Disease of the Intestine by Expansion of Regulatory T Cells
por: Hashimoto, Akari, et al.
Publicado: (2016)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
por: Tanaka, Yoshiya, et al.
Publicado: (2016)

Extracorporeal Membrane Oxygenation with rituximab‐combined chemotherapy in AIDS‐associated primary cardiac lymphoma: A case report
por: Fuseya, Hoyuri, et al.
Publicado: (2021)

Glucocorticoids and Antivirals for HBV Reactivation in Onco-Hematologic Patients.
por: Marzano, Alfredo, et al.
Publicado: (2010)

Impairment of tissue repair in pneumonia due to β-cell deficiency: role of endoplasmic reticulum stress in alveolar macrophages
por: Yamashita, Yoshiro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ko4toi8oarsjfds3oglkh8o62f